Your browser doesn't support javascript.
loading
Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study.
Owada, Yasuko; Okazaki, Mika; Ikeda, Toshiaki; Yamamoto, Ryuji; Minami, Kohtaro; Takahashi, Kenichi; Hirato, Tohru; Mita, Yoko; Yamamoto, Tatsuyoshi; Tanizawa, Kazunori; Sonoda, Hiroyuki; Sato, Yuji.
Affiliation
  • Owada Y; Medical Corporation Heishinkai OPHAC Hospital, Osaka, Japan.
  • Okazaki M; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: okazaki-m@jp.jcrpharm.com.
  • Ikeda T; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: ikeda-t@jp.jcrpharm.com.
  • Yamamoto R; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: yamamoto-ryu@jp.jcrpharm.com.
  • Minami K; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: minami-k@jp.jcrpharm.com.
  • Takahashi K; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: takahasi@jp.jcrpharm.com.
  • Hirato T; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: hirato-t@jp.jcrpharm.com.
  • Mita Y; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: mita@jp.jcrpharm.com.
  • Yamamoto T; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: t-yamamoto@jp.jcrpharm.com.
  • Tanizawa K; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: tanizawa-k@jp.jcrpharm.com.
  • Sonoda H; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: sonoda-h@jp.jcrpharm.com.
  • Sato Y; JCR Pharmaceuticals, Hyogo, Japan. Electronic address: sato-yuji@jp.jcrpharm.com.
Growth Horm IGF Res ; 67: 101500, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36113378

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Human Growth Hormone / Dwarfism, Pituitary Type of study: Clinical_trials / Guideline Aspects: Ethics Limits: Humans / Male Language: En Journal: Growth Horm IGF Res Journal subject: ENDOCRINOLOGIA Year: 2022 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Human Growth Hormone / Dwarfism, Pituitary Type of study: Clinical_trials / Guideline Aspects: Ethics Limits: Humans / Male Language: En Journal: Growth Horm IGF Res Journal subject: ENDOCRINOLOGIA Year: 2022 Document type: Article Affiliation country: Japón